All Articles

From my desk in The Engine Room, I analyze the blueprint behind Thirsty Buddha's bold leap from Canada into Costco UK and LA. This is more than a drink launch.

Prolium Bioscience advances its T-cell engager, PRO-203, in trials for scleroderma and lupus, heralding a new, potent strategy against severe autoimmunity.

Quectel's new Manaus R&D hub is more than an expansion; it's a strategic move to leverage Brazil's unique tech incentives and talent for regional IoT leadership.

bioAffinity Technologies' new gene-silencing therapy kills common skin cancer cells in lab studies while leaving healthy cells untouched, hinting at a future without scars.

Australian radiopharma innovator AdvanCell is planting its flag in Greater Boston with a new HQ and factory, a strategic move to scale its potent Lead-212 therapy.

With a pivotal drug approval on the horizon, Spruce Biosciences' appointment of a rare disease veteran signals a critical transition from R&D to commercial reality.

Chinese innovator Kandi Technologies is aggressively expanding its off-road vehicle business, a strategic pivot that bets on deep localization over pure volume.

With 1 in 4 seniors facing isolation, Element Care is using a $100K grant to prove that belonging is a clinical imperative, not just a 'nice-to-have'.

A new product launch isn't just about a product. It's a strategic move to expose a 'quality crisis' and force transparency in the booming mushroom market.

Jim Rowley's EY Entrepreneur of the Year award is more than a win for Crunch Fitness. It's a masterclass in applying military discipline to a disruptive business model.

Provincial ministers met to refocus their collective strategy, confronting the dual challenges of AI integration and unilateral federal policies on international students.

Hubstaff's 'Time Tracking Solution of the Year' award highlights a pivotal industry shift from simple monitoring to a trust-based model of remote management.

With compelling Phase 2b survival data, NeuroSense is advancing its multi-target ALS drug to a pivotal Phase 3 trial. A deep dive into the science and strategy.

A CAD$40M military contract validates NorthStar's space tech, bolsters Canada's sovereignty, and fuels its high-stakes journey to the public market.

ToonieBet's new partnership with the Hamilton Tiger-Cats is not just a sponsorship. It's a calculated move in Ontario's $66B iGaming arena. Here's why.

How the 75-year-old denim icon is weaving its authentic heritage into the fabric of modern country music through a strategic, nationwide festival tour.

Doosan Robotics' new AI solutions promise unprecedented efficiency. But beyond the demos, a deeper look reveals the challenges of skill gaps and the true cost of an automated future.

As Saint-Jean-Baptiste Day nears, MADD Canada's plea reveals a deeper issue: Quebec's outlier status on a road safety policy proven to save lives and money.

Masimo's FDA-cleared AI monitor for opioid risk does more than track vitals; it predicts danger, pushing healthcare from reactive alarms to proactive intervention.

A new partnership aims to close the gap between audience insight and ad activation. But does this 'agentic' model truly deliver the ROI brands demand?